Broadcom vs. Navitas Semiconductor: Which AI Chip Maker Stock Is a Better Buy in 2026?

Broadcom (AVGO) is framed as a cash-generating AI networking leader with FY2025 revenue of ~$63.9B (+~24% YoY) and net income of ~$23.1B (net margin ~36.2%), supporting free cash flow of ~$26.9B. By contrast, Navitas (NVTS) is described as a higher-risk pivot to GaN/SIC power materials: FY2025 revenue fell to ~$45.9M (-~45% YoY) with a net loss of ~$117.0M and negative free cash flow of -$44.4M, amid execution risks tied to TSMC exiting GaN production by mid-2027. The piece also cites valuation and Street expectations that position AVGO as the preferred 2026 pick due to cheaper P/S (~23.9x vs Navitas ~88.3x) and projected revenue/profit momentum, while NVTS remains a speculative turnaround.

Analysis

AVGO remains the cleaner way to express AI capex because its revenue is tied to the networking and software layers that stay in demand even if model training spend normalizes. The market should treat that as a quality-duration trade: if hyperscalers keep building inference clusters, Broadcom’s mix should support multiple resilience, while any pullback in AI orders would first show up as a growth-rate deceleration rather than an earnings cliff. The real second-order risk is concentration: supply-chain friction at TSM and customer consolidation can hit valuation before they hit reported numbers.

NVTS is a very different instrument: it is effectively a balance-sheet-backed call option on future power-delivery adoption, not a self-funding compounder. The strategic pivot creates a non-linear setup, but the near-term issue is execution drag: qualification cycles are long, revenue is still shrinking, and the company may need capital before the pivot becomes visible in shipments. That makes it vulnerable to down-round sentiment if the Nvidia-linked opportunity slips by even two quarters.

The contrarian take is that the market may be overpricing certainty on AVGO and underpricing the probability that NVTS remains a capital-consumption story for longer than expected. If AVGO trades like an AI utility, any sign of customer digestion or slower distributor sell-through could compress the multiple quickly. For NVTS, the catalyst path is binary: a credible foundry transition plus meaningful design-win conversion could rerate the stock sharply, but absent that, the base case remains dilution risk and continued underperformance versus AVGO and NVDA.

Key Decisions for Investors

• Long AVGO / short NVTS as a 3-6 month quality-vs-execution pair; expect AVGO to outperform on recurring AI infrastructure demand while NVTS remains exposed to cash burn and delayed monetization. Falsifier: NVTS announces a qualified volume ramp or AVGO guides down on AI networking demand.
• Add AVGO on weakness only if the stock is sold off on generic AI capex fears; the setup is strongest when sentiment turns from euphoria to scrutiny. Risk/reward favors buying dips because the downside is usually multiple compression, not a business reset.
• Avoid initiating a fresh NVTS long until there is verifiable foundry migration progress or disclosed revenue traction from the Nvidia power-delivery opportunity. If you want upside exposure, use a small starter position only after the next two quarters confirm design-win conversion.
• Watch GFS as a secondary beneficiary of any GaN manufacturing migration out of TSM; it is a higher-risk, lower-certainty way to play the supply-chain reconfiguration. Falsifier: Navitas chooses a different manufacturing path or qualification delays push revenue out beyond 2027.
• Set an alert on TSM-related supply disruptions and AVGO gross margin commentary; if Broadcom’s mix or supply chain weakens, the market will likely de-rate the stock before earnings revisions show up.